Akt Polyclonal Antibody, 50ul[BT-AP00339] Lentiviral Packaging is involved in the reduction

is involved in the reduction of biogenic and xenobiotic aldehydes and is present in virtually every tissue

Splice variants have been found for this gene

Mutation in this gene has been associated with Amish infantile epilepsy syndrome

GeneID 5307)

NF-kappa-B moves to the nucleus and activates transcription of specific genes

Akt Polyclonal Antibody, 50ul[BT-AP00339] Lentiviral Packaging is involved in the reductionThe serine threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3 kinase. In the developing nervous system AKT is a